MSN Laboratories
MSN Laboratories is a manufacturer of peptides based in India (Hyderabad). Direct manufacturer. Founded 2003. Key products include peptide APIs, generic APIs.
Listing reviewed October 2026.
About MSN Laboratories
Hyderabad-based generic pharmaceutical group making APIs and finished formulations. Its semaglutide and tirzepatide API Drug Master Files are filed by the group company MSN Life Sciences Private Ltd.
Directory assessment: MSN Laboratories is listed as a manufacturer in the peptide supply chain, serving Asia markets from India (Hyderabad). As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. This profile lists 2 sources for reference. This supplier has a medium confidence score — verification signals are present, but the listing is newer or less documented; perform standard due diligence before engaging.
- Semaglutide: DMF 38729 (Type II, active), submitted 2023-09-23
- Tirzepatide: DMF 43540 (Type II, active), submitted 2026-02-11
DMF numbers from the FDA quarterly DMF list. A filed DMF is not FDA approval; its contents are confidential. Reviewed 2026-10-15.